INCARCERATION AND OPIOID WITHDRAWAL: THE EXPERIENCES OF METHADONE PATIENTS AND OUT OF TREATMENT HEROIN USERS
Wedi'i Gadw mewn:
MITCHELL, S.G., ET AL., INCARCERATION AND OPIOID WITHDRAWAL: THE EXPERIENCES OF METHADONE PATIENTS AND OUT OF TREATMENT HEROIN USERS. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 41, no. 2 (2009), p. 145-152.
Ref.
161935
Lleoliad:
SIIS R.829 Archivo
Palabras clave:
Autoinformes, Delincuencia, Desintoxicación, Drogas ilegales, Drogodependencias, Estudio cualitativo, No tratamiento, Opiáceos, Prisión
Autoinformes, Delincuencia, Desintoxicación, Drogas ilegales, Drogodependencias, Estudio cualitativo, No tratamiento, Opiáceos, Prisión
Eitemau Tebyg: INCARCERATION AND OPIOID WITHDRAWAL: THE EXPERIENCES OF METHADONE PATIENTS AND OUT OF TREATMENT HEROIN USERS
- BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL
- SCIENTIFIC EVIDENCE AND PRACTICAL EXPERIENCE WITH METHADONE-ASSISTED WITHDRAWAL OF HEROIN-DEPENDENT PREGNANT PATIENTS
- Comparing the life concerns of prescription opioid and heroin users
- THE SUBJECTIVE OPIOID WITHDRAWAL SCALE 'SOWS'. EN:NATIONAL CLINIC GUIDELINES AND PROCEDURES FOR THE USE OF BUPRENORPHINE IN THE TREATMENT OF HEROIN DEPENDENCE
- FOUR YEAR FOLLOW-UP OF IMPRISONED MALE HEROIN USERS AND METHADONE TREATMENT: MORTALITY, RE-INCARCERATION AND HEPATITIS C INFECTION
- THE SUBJECTIVE OPIATE WITHDRAWAL SCALE (SOWS). EN: CLINICAL GUIDELINES AND PROCEDURES FOR THE USE OF NALTREXONE IN THE MANAGEMENT OF OPIOID DEPENDENCE